Globus Medical prelim Q4 sales $657M (+6.6% YoY), FY24 $2.52B; guides FY25 rev $2.66-2.69B

GLOBUS MEDICAL INC

2024-FY EPS reported $0.75 revenue$2,519,355,000

Q4 2024 preliminary net sales ~$657M, up 6.6% as-reported vs Q4 2023; FY2024 ~$2.52B, up 60.6%.
FY2025 revenue guidance $2.66-2.69B; fully diluted non-GAAP EPS $3.40-$3.50.
CEO highlights record product launches and highest Enabling Technology placements post-NuVasive merger.
Full Q4 and FY2024 results to be reported on February 20, 2025 after market close.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.